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SUMMARY Pemphigus vulgaris (PV) and pemphigus foliaceus 
(PF) are autoimmune blistering diseases characterized by in-
traepidermal separation as the result of autoantibodies directed 
to desmoglein 1 and desmoglein 3, adhesion molecules that 
have a pathogenic role in blister formation. Both PV and PF 
are diagnosed according to clinical picture, histopathologic, im-
munopathologic and molecular biologic features. In the pres-
ent study, the value of indirect immunofluorescence (IIF) and 
enzyme linked immunosorbent assay (ELISA) for desmoglein 
1 (Dsg 1) and desmoglein 3 (Dsg 3) at baseline visit was com-
pared. The study was performed as a retrospective study that 
included 22 patients, 19 of them with PV and three with PF. 
Patient sera were tested with IIF and Dsg 1 and Dsg 3 ELISA. 
In the group of 19 PV patients, 12 patients had positive IIF, Dsg 
3 and Dsg 1 ELISA; two had positive IIF and positive anti Dsg 
3 but negative anti Dsg 1; three had negative IIF but positive 
both Dsg 1 and Dsg 3 antibodies; and two had negative IIF and 
Dsg 1 but positive Dsg 3 antibodies. In the group of PF patients, 
all three patients had positive IIF, positive Dsg 1 ELISA and 
negative Dsg 3 ELISA. Results of our study supported previous 
reports confirming Dsg 1 and Dsg 3 ELISA to be a sensitive and 
specific tool for the diagnosis of PV and PF.
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INTRODUCTION
 Pemphigus is a group of autoimmune blister-
ing diseases characterized with intraepidermal 
blisters and erosions on the skin and/or mucous 
membranes. Two main forms of pemphigus are 
pemphigus vulgaris (PV) and pemphigus folia-
ceus (PF), each of them having few subtypes (1). 
These two major forms of pemphigus are distin-
guishable from each other according to clinical 
picture, histopathologic, immunopathologic and 
molecular biologic features (2). In PF blisters and 
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erosions appear most often on the face and trunk 
without involvement of oral mucosa, while histopa-
thology shows subcorneal acantholytic bullae. In 
PV patients blisters present as flaccid bullae and 
erosions on the skin, almost always associated 
and often preceded by oral mucosal lesion, while 
histopathology shows suprabasilar acantholytic 
bullae in lower epidermis (2,3). Blisters in PV and 
PF result from the presence of circulating IgG au-
toantibodies directed to desmoglein 3 (Dsg 3) and 
desmoglein 1 (Dsg 1). Both Dsg 1 and Dsg 3 are 
full length transmembrane proteins that belong 
to the cadherin family, are expressed in stratified 
squamous epithelia and play pathogenic roles in 
blister formation in PF and PV, respectively (2,3). 
Patients with PV whose disease is restricted to mu-
cosa mostly have autoantibodies directed against 
Dsg 3 and patients with lesions on the skin and 
mucous membrane have both autoantiboides di-
rected against Dsg 1 and Dsg 3. Autoantibodies di-
rected to desmoglein 1 are characteristically found 
in PF patients (4). The diagnosis of the pemphigus 
group of diseases is based on clinical picture and 
history, histopathologic diagnosis, and direct and 
indirect immunofluorescence (IIF). Since the intro-
duction of commercially available enzyme-linked 
immunosorbent assay (ELISA) kits for Dsg 3 and 
Dsg 1, these tests have been used as an addi-
tional diagnostic tool for diagnosing PV and PF 
(5). In most cases, the specificity of ELISA results 
reflects the clinical phenotype of the disease (2). 
ELISA index also provides a valuable tool to moni-
tor disease activity because recent studies show 
that ELISA index values fluctuate in parallel with 
disease activity (6-8).
AIM OF THE STUDY
 The aim of the study was to compare diagnos-
tic value of IIF and Dsg 1 and Dsg 3 ELISA as a 
tool in diagnosing and distinguishing between PV 
and PF. The usefulness of Dsg 1 and Dsg 3 ELISA 
in the diagnosis of pemphigus in Croatian patients 
has not yet been reported. This study is part of 
the scientific project entitled Autoimmune Blister-
ing Diseases in Croatia, the main goal of which 
is to give an overview of various aspects of these 
diseases in the Republic of Croatia.
PATIENTS AND METHODS
 Patients
 This retrospective study included 22 patients 
with PV and PF referred to our Department be-
tween January 1, 2008 and June 30, 2009. In this 
study, only results of IIF and Dsg 1 and Dsg 3 ELI-
SA at baseline visit were used. Prior to inclusion in 
the study, patients were diagnosed with PV or PF 
according to clinical picture, histopathologic and/
or immunofluorescence features. The study was 
approved by the Ethics Committee of the Zagreb 




 Normal human skin was used as a substrate 
for IIF assay. Patient sera were diluted up to 1:320 
for IgG antibodies.
 ELISA
 The sera of all 22 patients were tested using 
Dsg 1 and Dsg 3 ELISA kits (MESACUP Desmo-
glein test, MBL, Nagoya, Japan) according to the 
manufacturer’s instructions. The absorbance of 
each well was read at 450 nm by an automated 
plate reader (Asys Hitech Model Expert Plus). 
Positive and negative calibrators provided in the 
kit were included in each run. On evaluation of the 
sensitivity and specificity of ELISA, the cut-off val-
ues of 14 U/mL for Dsg 1 and 7 U/mL for Dsg 3 
were considered.
 Statistics
 On statistical analysis, the STATISTICA Ver-
sion 8 (StatSoft, Inc.) software was used.
RESULTS
Results are presented in tables and figures. 
The analysis included sera from 22 patients (Table 
1). PV was previously diagnosed in 19 and PF in 
three patients. All three patients with PF diagnosed 
at our Department were females. In the PV group, 
there were 15 female and four male patients (fe-
male to male ratio, 3.75:1). 
 In the group of PF patients, all three patients 
had positive IIF, positive anti Dsg 1 ELISA and 
negative anti Dsg 3 ELISA.
 In the group of 19 patients with PV, 12 (62.15%) 
patients had positive IIF, Dsg 3 and Dsg 1 ELISA 
(all parameters); two (10.5%) of them had positive 
IIF and positive anti Dsg 3 but negative anti Dsg 1; 
three (15.78%) had negative IIF but positive both 
Dsg 1 and Dsg 3 antibodies; and two (10.5%) had 
negative IIF and Dsg 1 but positive Dsg 3 antibod-
ies (Fig. 1).
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Table 2. Comparison between IIF and Dsg 1 ELI-
SA in pemphigus vulgaris patients
  IIF  
Dsg 1 0 1  
0 2 2 4 (21.1%)






 Using χ2-test, the distribution of positive results 
between Dsg 1 ELISA and IIF assay was not sta-
tistically significant (p=0.2260) (Table 2).
 Thus, it was not possible to use χ2-test for com-
paring Dsg 3 and IIF because Dsg 3 results were 
positive in all patients (Table 3, Fig. 2).
Table 3. Comparison between IIF and Dsg 3 ELI-
SA in pemphigus vulgaris patients
  IIF  
DSG 3 0 1  






Table 1. Results of indirect immunofluorescence (IIF), anti Dsg 1 and anti Dsg 3 ELISA
No. Sex (male/
female)
Diagnosis IIF Dsg 1 Dsg 3
1 F PV +   1:40 + 133 + 171
2 M PV - + 19 +120
3 F PV +  1:80 + 112 + 185
4 M PV >  1:320 + 203 + 414
5 F PV +  1:40 + 124 + 147
6 F PV +  1:80 + 205 + 86
7 F PV - - + 97
8 M PV +  1:320 + 173 + 174
9 F PV >  1:320 + 88 + 524
10 F PV +  1:80 + 72 + 504
11 F PV - - + 161
12 F PV - + 37 + 9
13 F PV +  1:320 + 116 + 173
14 F PV +  1:20 - + 162
15 F PV - + 74 + 26
16 F PV +  320 + 82 + 191
17 M PV +  1:40 - + 204
18 F PV +  1:20 + 15 + 198
19 F PV +  1:80 + 192 + 232
20 F PF +  1:80 + 176 -
21 F PF +  1:320 + 198 -
22 F PF +  1:80 + 294 -
Figure 1. Dsg 1 ELISA and IIF parameters in pem-
phigus vulgaris patients.
Bivariate Histogram of DSG1 against IIF
 IIF:DSG1:   Chi2 = 1,4657; p = 0,2260; N = 19I sg Chi2=1.4657; p=0.2260; N = 19
i ri t  hi t ra  of Dsg 1 against IIF
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Bivariate Histogram of DSG3 against IIF
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DISCUSSION
 The aim of our study was to compare IIF assay 
and Dsg 1 and Dsg 3 ELISA as a tool in the diag-
nosis of PV and PF in Croatian patients. In the PF 
group, all three patients had positive IIF and Dsg 1 
and negative Dsg 3, which is comparable with the 
current knowledge, yet the group was too small for 
statistical analysis (2-4). Any comparison of their 
results with the others or to make any valid conclu-
sion, a larger patient group and additional studies 
are needed.
 In the PV group, five of 19 (26.3%) patients 
had negative IIF and positive Dsg 3 and/or Dsg 
1 ELISA. Although IIF is useful for identifying an-
tibodies, there is the possibility of false negative 
results due to substrate sensitivity, technical error, 
and also very rarely prozone phenomenon (9). 
The possible reason for some negative IIF results 
was the fact that we used human skin as a sub-
strate for IIF assay, and not monkey esophagus 
(in which is Dsg 3 is strongly expressed in the 
epithelium) which is reported as a more sensitive 
substrate for pemphigus patients (2). 
 In the group of PV patients, 15 of 19 (78.9%) 
patients had positive anti Dsg 1 antibodies and all 
patients (100%) had positive anti Dsg 3 antibod-
ies, which is comparable with the study by Atzori 
et al. (10).  Our results are also comparable with 
the study by Abasq et al.,  who report that their 
results of ELISA at baseline confirmed the previ-
ously reported correlation between clinical pheno-
type of patients and recognition of Dsg 1 and Dsg 
3 in serum. However, they also found the Dsg 1 
ELISA antibody values to more closely correlate 
than anti Dsg 3 antibodies during follow up (11).
 In our group of patients, clinical phenotype 
was related to the antibody profile. There are oc-
casional reports of cases with discordant clinical 
phenotype and antibody profile (12-14). The pres-
ent study supported previous reports on ELISA for 
anti Dsg 1 and Dsg 3 antibodies to be a sensitive 
and specific tool for the diagnosis of pemphigus 
(9). According to the authors and our latest experi-
ence (unpublished data), it can also serve as a 
predictive means to monitor disease activity (2,5).
Unlike IIF, one of the advantages of ELISA is that 
it does not require specifically skilled observer. It 
also reflects disease activity in early stages better 
than IIF (7).
CONCLUSION
 Dsg 1 and Dsg 3 ELISA is a sensitive tool for 
diagnosing pemphigus, in which positive Dsg 3 
antibodies are indicative of PV, regardless of the 
associated Dsg 1 result. Positive Dsg 1 with neg-
ative Dsg 3 is indicative of the diagnosis of PF. 
ELISA is not only a sensitive diagnostic tool, as it 
can also serve as a predictive means to monitor 
disease activity. There is a need of more patients 
to be included in further studies comparing the two 
methods, but also to assess the follow up index 
values of Dsg 1 and Dsg 3 ELISA.
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